Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01087814 · ClinicalTrials.gov registry record · Phase 4
Sustiva Levels With Use of a Gel Capsule
A Phase 4 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT01087814 is a Phase 4 study that has completed, run by University of Minnesota. The registered enrollment target is 16 participants.
The verdict
NCT01087814, a Phase 4 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
We are studying if putting a gel capsule over a standard HIV drug changes the ability of the body to absorb the drug. This is important because we want to be able to study new HIV drugs against the most common drugs used today and the most common is Sustiva, which is also called efavirenz. We will give you Sustiva every day for 5 days and draw blood to see how much is absorbed. Then we will give you Sustiva that has a gel capsule over it for 5 days and we will draw blood to see how much is absorbed.
Interventions
- DRUG Efavirenz
- DRUG Over-encapsulated efavirenz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01087814
The ClinicalTrials.gov registry entry for NCT01087814 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Efavirenz is the first listed.
NCT01087814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01087814 about?
NCT01087814 is a clinical study titled "Sustiva Levels With Use of a Gel Capsule". We are studying if putting a gel capsule over a standard HIV drug changes the ability of the body to absorb the drug. This is important because we want to be able to study new HIV drugs against the most common drugs used today and the most common is Sustiva, which is also called efavirenz. We will g...
What is the current status of trial NCT01087814?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2010-02. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01087814?
The interventions under investigation include: Efavirenz (DRUG), Over-encapsulated efavirenz (DRUG).
Who is sponsoring clinical trial NCT01087814?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.